nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP3A4—bone cancer	0.656	1	CbGaD
Bupropion—CYP2B6—Cisplatin—bone cancer	0.0217	0.366	CbGbCtD
Bupropion—CYP2B6—Doxorubicin—bone cancer	0.0145	0.246	CbGbCtD
Bupropion—CYP2C9—Cisplatin—bone cancer	0.0115	0.194	CbGbCtD
Bupropion—CYP2D6—Doxorubicin—bone cancer	0.00702	0.119	CbGbCtD
Bupropion—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00486	0.0737	CbGpPWpGaD
Bupropion—CYP3A4—Doxorubicin—bone cancer	0.00446	0.0754	CbGbCtD
Bupropion—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00292	0.0443	CbGpPWpGaD
Bupropion—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00202	0.0306	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00163	0.0247	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0016	0.0242	CbGpPWpGaD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00138	0.0209	CbGpPWpGaD
Bupropion—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00137	0.0208	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00132	0.02	CbGpPWpGaD
Bupropion—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00117	0.0177	CbGpPWpGaD
Bupropion—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00114	0.0172	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00113	0.0172	CbGpPWpGaD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00112	0.017	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00107	0.0163	CbGpPWpGaD
Bupropion—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00107	0.0163	CbGpPWpGaD
Bupropion—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.000975	0.0148	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000959	0.0145	CbGpPWpGaD
Bupropion—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000937	0.0142	CbGpPWpGaD
Bupropion—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000921	0.014	CbGpPWpGaD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00088	0.0133	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000862	0.0131	CbGpPWpGaD
Bupropion—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000786	0.0119	CbGpPWpGaD
Bupropion—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000771	0.0117	CbGpPWpGaD
Bupropion—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00077	0.0117	CbGpPWpGaD
Bupropion—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000741	0.0112	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00074	0.0112	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000701	0.0106	CbGpPWpGaD
Bupropion—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000697	0.0106	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000687	0.0104	CbGpPWpGaD
Bupropion—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000669	0.0101	CbGpPWpGaD
Bupropion—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000666	0.0101	CbGpPWpGaD
Bupropion—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000653	0.0099	CbGpPWpGaD
Bupropion—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.00064	0.0097	CbGpPWpGaD
Bupropion—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000607	0.0092	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000594	0.009	CbGpPWpGaD
Bupropion—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000554	0.00839	CbGpPWpGaD
Bupropion—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000547	0.00828	CbGpPWpGaD
Bupropion—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000542	0.00821	CbGpPWpGaD
Bupropion—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00054	0.00818	CbGpPWpGaD
Bupropion—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000526	0.00797	CbGpPWpGaD
Bupropion—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000521	0.0079	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000518	0.00786	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000516	0.00783	CbGpPWpGaD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000514	0.0078	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000504	0.00764	CbGpPWpGaD
Bupropion—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000504	0.00764	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000487	0.00739	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000483	0.00732	CbGpPWpGaD
Bupropion—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000482	0.00731	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000465	0.00706	CbGpPWpGaD
Bupropion—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000463	0.00702	CbGpPWpGaD
Bupropion—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000445	0.00675	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000413	0.00626	CbGpPWpGaD
Bupropion—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000405	0.00613	CbGpPWpGaD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0004	0.00606	CbGpPWpGaD
Bupropion—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000399	0.00605	CbGpPWpGaD
Bupropion—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000396	0.006	CbGpPWpGaD
Bupropion—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000372	0.00564	CbGpPWpGaD
Bupropion—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000354	0.00537	CbGpPWpGaD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000328	0.00497	CbGpPWpGaD
Bupropion—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000327	0.00495	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000322	0.00488	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00032	0.00485	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000319	0.00483	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000316	0.00478	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000303	0.00459	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000279	0.00423	CbGpPWpGaD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000276	0.00419	CbGpPWpGaD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000273	0.00414	CbGpPWpGaD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000265	0.00401	CbGpPWpGaD
Bupropion—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000261	0.00396	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000259	0.00393	CbGpPWpGaD
Bupropion—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000238	0.0036	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000234	0.00355	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—GSTP1—bone cancer	0.00023	0.00348	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—TGFBR2—bone cancer	0.00023	0.00348	CbGpPWpGaD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000227	0.00344	CbGpPWpGaD
Bupropion—Erythema multiforme—Methotrexate—bone cancer	0.000226	0.00103	CcSEcCtD
Bupropion—Neuropathy peripheral—Doxorubicin—bone cancer	0.000226	0.00103	CcSEcCtD
Bupropion—Haemoglobin—Epirubicin—bone cancer	0.000225	0.00103	CcSEcCtD
Bupropion—Stomatitis—Doxorubicin—bone cancer	0.000225	0.00103	CcSEcCtD
Bupropion—Jaundice—Doxorubicin—bone cancer	0.000225	0.00103	CcSEcCtD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000225	0.00341	CbGpPWpGaD
Bupropion—Rhinitis—Epirubicin—bone cancer	0.000225	0.00103	CcSEcCtD
Bupropion—Urinary tract infection—Doxorubicin—bone cancer	0.000224	0.00102	CcSEcCtD
Bupropion—Conjunctivitis—Doxorubicin—bone cancer	0.000224	0.00102	CcSEcCtD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000224	0.0034	CbGpPWpGaD
Bupropion—Hepatitis—Epirubicin—bone cancer	0.000224	0.00102	CcSEcCtD
Bupropion—Haemorrhage—Epirubicin—bone cancer	0.000224	0.00102	CcSEcCtD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000224	0.00339	CbGpPWpGaD
Bupropion—Eye disorder—Methotrexate—bone cancer	0.000224	0.00102	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—bone cancer	0.000223	0.00102	CcSEcCtD
Bupropion—Hypoaesthesia—Epirubicin—bone cancer	0.000223	0.00102	CcSEcCtD
Bupropion—Asthenia—Cisplatin—bone cancer	0.000222	0.00101	CcSEcCtD
Bupropion—Pharyngitis—Epirubicin—bone cancer	0.000222	0.00101	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—bone cancer	0.000222	0.00101	CcSEcCtD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000222	0.00337	CbGpPWpGaD
Bupropion—Sweating—Doxorubicin—bone cancer	0.000221	0.00101	CcSEcCtD
Bupropion—Urinary tract disorder—Epirubicin—bone cancer	0.000221	0.00101	CcSEcCtD
Bupropion—Oedema peripheral—Epirubicin—bone cancer	0.000221	0.00101	CcSEcCtD
Bupropion—Connective tissue disorder—Epirubicin—bone cancer	0.00022	0.001	CcSEcCtD
Bupropion—Urethral disorder—Epirubicin—bone cancer	0.00022	0.001	CcSEcCtD
Bupropion—Epistaxis—Doxorubicin—bone cancer	0.000218	0.000994	CcSEcCtD
Bupropion—Angiopathy—Methotrexate—bone cancer	0.000217	0.000991	CcSEcCtD
Bupropion—Sinusitis—Doxorubicin—bone cancer	0.000217	0.000989	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—bone cancer	0.000216	0.000987	CcSEcCtD
Bupropion—Visual impairment—Epirubicin—bone cancer	0.000216	0.000985	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—bone cancer	0.000216	0.000985	CcSEcCtD
Bupropion—Chills—Methotrexate—bone cancer	0.000215	0.00098	CcSEcCtD
Bupropion—Diarrhoea—Cisplatin—bone cancer	0.000212	0.000968	CcSEcCtD
Bupropion—Erythema multiforme—Epirubicin—bone cancer	0.000212	0.000967	CcSEcCtD
Bupropion—Alopecia—Methotrexate—bone cancer	0.000212	0.000965	CcSEcCtD
Bupropion—CHRNA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.00021	0.00318	CbGpPWpGaD
Bupropion—Mental disorder—Methotrexate—bone cancer	0.00021	0.000957	CcSEcCtD
Bupropion—Eye disorder—Epirubicin—bone cancer	0.000209	0.000955	CcSEcCtD
Bupropion—Tinnitus—Epirubicin—bone cancer	0.000209	0.000953	CcSEcCtD
Bupropion—Malnutrition—Methotrexate—bone cancer	0.000208	0.000951	CcSEcCtD
Bupropion—Haemoglobin—Doxorubicin—bone cancer	0.000208	0.000951	CcSEcCtD
Bupropion—Cardiac disorder—Epirubicin—bone cancer	0.000208	0.000949	CcSEcCtD
Bupropion—Flushing—Epirubicin—bone cancer	0.000208	0.000949	CcSEcCtD
Bupropion—Rhinitis—Doxorubicin—bone cancer	0.000208	0.000948	CcSEcCtD
Bupropion—Haemorrhage—Doxorubicin—bone cancer	0.000207	0.000946	CcSEcCtD
Bupropion—Hepatitis—Doxorubicin—bone cancer	0.000207	0.000946	CcSEcCtD
Bupropion—Hypoaesthesia—Doxorubicin—bone cancer	0.000206	0.000941	CcSEcCtD
Bupropion—Pharyngitis—Doxorubicin—bone cancer	0.000206	0.000939	CcSEcCtD
Bupropion—Urinary tract disorder—Doxorubicin—bone cancer	0.000205	0.000934	CcSEcCtD
Bupropion—Oedema peripheral—Doxorubicin—bone cancer	0.000204	0.000932	CcSEcCtD
Bupropion—Dysgeusia—Methotrexate—bone cancer	0.000204	0.000931	CcSEcCtD
Bupropion—Connective tissue disorder—Doxorubicin—bone cancer	0.000204	0.00093	CcSEcCtD
Bupropion—SLC6A3—NRF2 pathway—GSTP1—bone cancer	0.000203	0.00308	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—TGFBR2—bone cancer	0.000203	0.00308	CbGpPWpGaD
Bupropion—Angiopathy—Epirubicin—bone cancer	0.000203	0.000928	CcSEcCtD
Bupropion—Urethral disorder—Doxorubicin—bone cancer	0.000203	0.000927	CcSEcCtD
Bupropion—Immune system disorder—Epirubicin—bone cancer	0.000202	0.000924	CcSEcCtD
Bupropion—Mediastinal disorder—Epirubicin—bone cancer	0.000202	0.000921	CcSEcCtD
Bupropion—Back pain—Methotrexate—bone cancer	0.000202	0.00092	CcSEcCtD
Bupropion—Chills—Epirubicin—bone cancer	0.000201	0.000917	CcSEcCtD
Bupropion—Arrhythmia—Epirubicin—bone cancer	0.0002	0.000913	CcSEcCtD
Bupropion—Visual impairment—Doxorubicin—bone cancer	0.0002	0.000912	CcSEcCtD
Bupropion—Alopecia—Epirubicin—bone cancer	0.000198	0.000903	CcSEcCtD
Bupropion—Vomiting—Cisplatin—bone cancer	0.000197	0.000899	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—bone cancer	0.000196	0.000896	CcSEcCtD
Bupropion—Mental disorder—Epirubicin—bone cancer	0.000196	0.000896	CcSEcCtD
Bupropion—Erythema multiforme—Doxorubicin—bone cancer	0.000196	0.000894	CcSEcCtD
Bupropion—Rash—Cisplatin—bone cancer	0.000195	0.000892	CcSEcCtD
Bupropion—Dermatitis—Cisplatin—bone cancer	0.000195	0.000891	CcSEcCtD
Bupropion—Malnutrition—Epirubicin—bone cancer	0.000195	0.00089	CcSEcCtD
Bupropion—Eye disorder—Doxorubicin—bone cancer	0.000194	0.000884	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—bone cancer	0.000193	0.000882	CcSEcCtD
Bupropion—Tinnitus—Doxorubicin—bone cancer	0.000193	0.000882	CcSEcCtD
Bupropion—Anaemia—Methotrexate—bone cancer	0.000193	0.000879	CcSEcCtD
Bupropion—Cardiac disorder—Doxorubicin—bone cancer	0.000192	0.000878	CcSEcCtD
Bupropion—Flushing—Doxorubicin—bone cancer	0.000192	0.000878	CcSEcCtD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000192	0.00291	CbGpPWpGaD
Bupropion—Flatulence—Epirubicin—bone cancer	0.000192	0.000877	CcSEcCtD
Bupropion—Tension—Epirubicin—bone cancer	0.000191	0.000873	CcSEcCtD
Bupropion—Dysgeusia—Epirubicin—bone cancer	0.000191	0.000872	CcSEcCtD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00019	0.00288	CbGpPWpGaD
Bupropion—Nervousness—Epirubicin—bone cancer	0.000189	0.000864	CcSEcCtD
Bupropion—Back pain—Epirubicin—bone cancer	0.000189	0.000861	CcSEcCtD
Bupropion—Angiopathy—Doxorubicin—bone cancer	0.000188	0.000858	CcSEcCtD
Bupropion—Malaise—Methotrexate—bone cancer	0.000188	0.000858	CcSEcCtD
Bupropion—Muscle spasms—Epirubicin—bone cancer	0.000187	0.000856	CcSEcCtD
Bupropion—Immune system disorder—Doxorubicin—bone cancer	0.000187	0.000855	CcSEcCtD
Bupropion—Vertigo—Methotrexate—bone cancer	0.000187	0.000854	CcSEcCtD
Bupropion—Mediastinal disorder—Doxorubicin—bone cancer	0.000187	0.000853	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—bone cancer	0.000187	0.000851	CcSEcCtD
Bupropion—Chills—Doxorubicin—bone cancer	0.000186	0.000849	CcSEcCtD
Bupropion—Arrhythmia—Doxorubicin—bone cancer	0.000185	0.000845	CcSEcCtD
Bupropion—Nausea—Cisplatin—bone cancer	0.000184	0.00084	CcSEcCtD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000184	0.00279	CbGpPWpGaD
Bupropion—Vision blurred—Epirubicin—bone cancer	0.000184	0.000839	CcSEcCtD
Bupropion—Alopecia—Doxorubicin—bone cancer	0.000183	0.000836	CcSEcCtD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000182	0.00276	CbGpPWpGaD
Bupropion—Cough—Methotrexate—bone cancer	0.000182	0.00083	CcSEcCtD
Bupropion—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000182	0.00276	CbGpPWpGaD
Bupropion—Mental disorder—Doxorubicin—bone cancer	0.000182	0.000829	CcSEcCtD
Bupropion—Ill-defined disorder—Epirubicin—bone cancer	0.000181	0.000826	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000181	0.00274	CbGpPWpGaD
Bupropion—Convulsion—Methotrexate—bone cancer	0.000181	0.000824	CcSEcCtD
Bupropion—Malnutrition—Doxorubicin—bone cancer	0.00018	0.000824	CcSEcCtD
Bupropion—Anaemia—Epirubicin—bone cancer	0.00018	0.000823	CcSEcCtD
Bupropion—Agitation—Epirubicin—bone cancer	0.000179	0.000818	CcSEcCtD
Bupropion—Flatulence—Doxorubicin—bone cancer	0.000178	0.000812	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—bone cancer	0.000177	0.00081	CcSEcCtD
Bupropion—Myalgia—Methotrexate—bone cancer	0.000177	0.00081	CcSEcCtD
Bupropion—Chest pain—Methotrexate—bone cancer	0.000177	0.00081	CcSEcCtD
Bupropion—Tension—Doxorubicin—bone cancer	0.000177	0.000808	CcSEcCtD
Bupropion—Dysgeusia—Doxorubicin—bone cancer	0.000177	0.000806	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000176	0.000804	CcSEcCtD
Bupropion—CHRNA3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000176	0.00267	CbGpPWpGaD
Bupropion—Malaise—Epirubicin—bone cancer	0.000176	0.000803	CcSEcCtD
Bupropion—Discomfort—Methotrexate—bone cancer	0.000175	0.0008	CcSEcCtD
Bupropion—Nervousness—Doxorubicin—bone cancer	0.000175	0.0008	CcSEcCtD
Bupropion—Vertigo—Epirubicin—bone cancer	0.000175	0.0008	CcSEcCtD
Bupropion—Syncope—Epirubicin—bone cancer	0.000175	0.000798	CcSEcCtD
Bupropion—Leukopenia—Epirubicin—bone cancer	0.000175	0.000797	CcSEcCtD
Bupropion—Back pain—Doxorubicin—bone cancer	0.000175	0.000797	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000174	0.00264	CbGpPWpGaD
Bupropion—Muscle spasms—Doxorubicin—bone cancer	0.000173	0.000792	CcSEcCtD
Bupropion—Palpitations—Epirubicin—bone cancer	0.000172	0.000787	CcSEcCtD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000172	0.00261	CbGpPWpGaD
Bupropion—Confusional state—Methotrexate—bone cancer	0.000171	0.000783	CcSEcCtD
Bupropion—Loss of consciousness—Epirubicin—bone cancer	0.000171	0.000782	CcSEcCtD
Bupropion—Cough—Epirubicin—bone cancer	0.00017	0.000777	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—bone cancer	0.00017	0.000776	CcSEcCtD
Bupropion—Vision blurred—Doxorubicin—bone cancer	0.00017	0.000776	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.00017	0.00258	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.00017	0.00258	CbGpPWpGaD
Bupropion—Convulsion—Epirubicin—bone cancer	0.000169	0.000771	CcSEcCtD
Bupropion—Infection—Methotrexate—bone cancer	0.000169	0.000771	CcSEcCtD
Bupropion—Hypertension—Epirubicin—bone cancer	0.000168	0.000768	CcSEcCtD
Bupropion—Ill-defined disorder—Doxorubicin—bone cancer	0.000167	0.000764	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—bone cancer	0.000167	0.000761	CcSEcCtD
Bupropion—Anaemia—Doxorubicin—bone cancer	0.000167	0.000761	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—bone cancer	0.000167	0.00076	CcSEcCtD
Bupropion—Myalgia—Epirubicin—bone cancer	0.000166	0.000758	CcSEcCtD
Bupropion—Arthralgia—Epirubicin—bone cancer	0.000166	0.000758	CcSEcCtD
Bupropion—Chest pain—Epirubicin—bone cancer	0.000166	0.000758	CcSEcCtD
Bupropion—Agitation—Doxorubicin—bone cancer	0.000166	0.000757	CcSEcCtD
Bupropion—Anxiety—Epirubicin—bone cancer	0.000165	0.000755	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—bone cancer	0.000165	0.000754	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000165	0.000753	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—bone cancer	0.000164	0.00075	CcSEcCtD
Bupropion—Discomfort—Epirubicin—bone cancer	0.000164	0.000749	CcSEcCtD
Bupropion—Malaise—Doxorubicin—bone cancer	0.000163	0.000743	CcSEcCtD
Bupropion—Dry mouth—Epirubicin—bone cancer	0.000162	0.000741	CcSEcCtD
Bupropion—Vertigo—Doxorubicin—bone cancer	0.000162	0.00074	CcSEcCtD
Bupropion—Anorexia—Methotrexate—bone cancer	0.000162	0.00074	CcSEcCtD
Bupropion—Syncope—Doxorubicin—bone cancer	0.000162	0.000739	CcSEcCtD
Bupropion—Leukopenia—Doxorubicin—bone cancer	0.000162	0.000737	CcSEcCtD
Bupropion—CHRNA3—Neuronal System—BRAF—bone cancer	0.000161	0.00244	CbGpPWpGaD
Bupropion—Confusional state—Epirubicin—bone cancer	0.00016	0.000732	CcSEcCtD
Bupropion—SLC6A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00016	0.00242	CbGpPWpGaD
Bupropion—Palpitations—Doxorubicin—bone cancer	0.000159	0.000728	CcSEcCtD
Bupropion—Anaphylactic shock—Epirubicin—bone cancer	0.000159	0.000726	CcSEcCtD
Bupropion—Oedema—Epirubicin—bone cancer	0.000159	0.000726	CcSEcCtD
Bupropion—Hypotension—Methotrexate—bone cancer	0.000159	0.000725	CcSEcCtD
Bupropion—Loss of consciousness—Doxorubicin—bone cancer	0.000159	0.000724	CcSEcCtD
Bupropion—Infection—Epirubicin—bone cancer	0.000158	0.000722	CcSEcCtD
Bupropion—Cough—Doxorubicin—bone cancer	0.000157	0.000719	CcSEcCtD
Bupropion—Shock—Epirubicin—bone cancer	0.000157	0.000715	CcSEcCtD
Bupropion—Convulsion—Doxorubicin—bone cancer	0.000156	0.000714	CcSEcCtD
Bupropion—Nervous system disorder—Epirubicin—bone cancer	0.000156	0.000712	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000156	0.00236	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000156	0.00236	CbGpPWpGaD
Bupropion—Thrombocytopenia—Epirubicin—bone cancer	0.000156	0.000711	CcSEcCtD
Bupropion—Hypertension—Doxorubicin—bone cancer	0.000156	0.000711	CcSEcCtD
Bupropion—Tachycardia—Epirubicin—bone cancer	0.000155	0.000709	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000155	0.000707	CcSEcCtD
Bupropion—Skin disorder—Epirubicin—bone cancer	0.000155	0.000706	CcSEcCtD
Bupropion—Hyperhidrosis—Epirubicin—bone cancer	0.000154	0.000702	CcSEcCtD
Bupropion—Insomnia—Methotrexate—bone cancer	0.000154	0.000702	CcSEcCtD
Bupropion—Chest pain—Doxorubicin—bone cancer	0.000154	0.000701	CcSEcCtD
Bupropion—Myalgia—Doxorubicin—bone cancer	0.000154	0.000701	CcSEcCtD
Bupropion—Arthralgia—Doxorubicin—bone cancer	0.000154	0.000701	CcSEcCtD
Bupropion—Anxiety—Doxorubicin—bone cancer	0.000153	0.000699	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—bone cancer	0.000153	0.000697	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000153	0.000696	CcSEcCtD
Bupropion—Discomfort—Doxorubicin—bone cancer	0.000152	0.000693	CcSEcCtD
Bupropion—Anorexia—Epirubicin—bone cancer	0.000152	0.000692	CcSEcCtD
Bupropion—Dyspnoea—Methotrexate—bone cancer	0.000152	0.000692	CcSEcCtD
Bupropion—Somnolence—Methotrexate—bone cancer	0.000151	0.00069	CcSEcCtD
Bupropion—Dry mouth—Doxorubicin—bone cancer	0.00015	0.000686	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—bone cancer	0.00015	0.000683	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000149	0.00226	CbGpPWpGaD
Bupropion—Hypotension—Epirubicin—bone cancer	0.000149	0.000679	CcSEcCtD
Bupropion—Confusional state—Doxorubicin—bone cancer	0.000148	0.000678	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—bone cancer	0.000148	0.000675	CcSEcCtD
Bupropion—Oedema—Doxorubicin—bone cancer	0.000147	0.000672	CcSEcCtD
Bupropion—Anaphylactic shock—Doxorubicin—bone cancer	0.000147	0.000672	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—bone cancer	0.000147	0.00067	CcSEcCtD
Bupropion—Fatigue—Methotrexate—bone cancer	0.000147	0.000669	CcSEcCtD
Bupropion—Infection—Doxorubicin—bone cancer	0.000146	0.000668	CcSEcCtD
Bupropion—Pain—Methotrexate—bone cancer	0.000145	0.000664	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000145	0.000662	CcSEcCtD
Bupropion—Shock—Doxorubicin—bone cancer	0.000145	0.000661	CcSEcCtD
Bupropion—Nervous system disorder—Doxorubicin—bone cancer	0.000144	0.000659	CcSEcCtD
Bupropion—Thrombocytopenia—Doxorubicin—bone cancer	0.000144	0.000658	CcSEcCtD
Bupropion—Insomnia—Epirubicin—bone cancer	0.000144	0.000657	CcSEcCtD
Bupropion—Tachycardia—Doxorubicin—bone cancer	0.000144	0.000656	CcSEcCtD
Bupropion—Skin disorder—Doxorubicin—bone cancer	0.000143	0.000653	CcSEcCtD
Bupropion—Paraesthesia—Epirubicin—bone cancer	0.000143	0.000652	CcSEcCtD
Bupropion—Hyperhidrosis—Doxorubicin—bone cancer	0.000142	0.00065	CcSEcCtD
Bupropion—Dyspnoea—Epirubicin—bone cancer	0.000142	0.000648	CcSEcCtD
Bupropion—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000142	0.00215	CbGpPWpGaD
Bupropion—Somnolence—Epirubicin—bone cancer	0.000141	0.000646	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000141	0.00213	CbGpPWpGaD
Bupropion—Anorexia—Doxorubicin—bone cancer	0.00014	0.000641	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—bone cancer	0.00014	0.00064	CcSEcCtD
Bupropion—Dyspepsia—Epirubicin—bone cancer	0.00014	0.000639	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—bone cancer	0.000139	0.000635	CcSEcCtD
Bupropion—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000139	0.0021	CbGpPWpGaD
Bupropion—Decreased appetite—Epirubicin—bone cancer	0.000138	0.000631	CcSEcCtD
Bupropion—SLC6A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000138	0.00209	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000138	0.00209	CbGpPWpGaD
Bupropion—Hypotension—Doxorubicin—bone cancer	0.000138	0.000628	CcSEcCtD
Bupropion—Gastrointestinal disorder—Epirubicin—bone cancer	0.000137	0.000627	CcSEcCtD
Bupropion—Fatigue—Epirubicin—bone cancer	0.000137	0.000626	CcSEcCtD
Bupropion—Pain—Epirubicin—bone cancer	0.000136	0.000621	CcSEcCtD
Bupropion—Constipation—Epirubicin—bone cancer	0.000136	0.000621	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000136	0.00206	CbGpPWpGaD
Bupropion—Urticaria—Methotrexate—bone cancer	0.000135	0.000617	CcSEcCtD
Bupropion—CHRNA3—Neuronal System—MDM2—bone cancer	0.000135	0.00204	CbGpPWpGaD
Bupropion—Abdominal pain—Methotrexate—bone cancer	0.000134	0.000614	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—bone cancer	0.000134	0.000614	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000134	0.000612	CcSEcCtD
Bupropion—Insomnia—Doxorubicin—bone cancer	0.000133	0.000608	CcSEcCtD
Bupropion—Paraesthesia—Doxorubicin—bone cancer	0.000132	0.000604	CcSEcCtD
Bupropion—Dyspnoea—Doxorubicin—bone cancer	0.000131	0.000599	CcSEcCtD
Bupropion—Feeling abnormal—Epirubicin—bone cancer	0.000131	0.000599	CcSEcCtD
Bupropion—Somnolence—Doxorubicin—bone cancer	0.000131	0.000598	CcSEcCtD
Bupropion—Gastrointestinal pain—Epirubicin—bone cancer	0.00013	0.000594	CcSEcCtD
Bupropion—Dyspepsia—Doxorubicin—bone cancer	0.00013	0.000592	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000128	0.00194	CbGpPWpGaD
Bupropion—Decreased appetite—Doxorubicin—bone cancer	0.000128	0.000584	CcSEcCtD
Bupropion—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000127	0.00058	CcSEcCtD
Bupropion—Fatigue—Doxorubicin—bone cancer	0.000127	0.000579	CcSEcCtD
Bupropion—Urticaria—Epirubicin—bone cancer	0.000126	0.000577	CcSEcCtD
Bupropion—Pain—Doxorubicin—bone cancer	0.000126	0.000575	CcSEcCtD
Bupropion—Constipation—Doxorubicin—bone cancer	0.000126	0.000575	CcSEcCtD
Bupropion—Body temperature increased—Epirubicin—bone cancer	0.000126	0.000574	CcSEcCtD
Bupropion—Abdominal pain—Epirubicin—bone cancer	0.000126	0.000574	CcSEcCtD
Bupropion—Hypersensitivity—Methotrexate—bone cancer	0.000125	0.000572	CcSEcCtD
Bupropion—Asthenia—Methotrexate—bone cancer	0.000122	0.000557	CcSEcCtD
Bupropion—Feeling abnormal—Doxorubicin—bone cancer	0.000121	0.000554	CcSEcCtD
Bupropion—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000121	0.00183	CbGpPWpGaD
Bupropion—Gastrointestinal pain—Doxorubicin—bone cancer	0.00012	0.00055	CcSEcCtD
Bupropion—Pruritus—Methotrexate—bone cancer	0.00012	0.000549	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.00012	0.00182	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000119	0.0018	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000119	0.0018	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000118	0.00179	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000117	0.00178	CbGpPWpGaD
Bupropion—Hypersensitivity—Epirubicin—bone cancer	0.000117	0.000535	CcSEcCtD
Bupropion—Urticaria—Doxorubicin—bone cancer	0.000117	0.000534	CcSEcCtD
Bupropion—Body temperature increased—Doxorubicin—bone cancer	0.000116	0.000531	CcSEcCtD
Bupropion—Abdominal pain—Doxorubicin—bone cancer	0.000116	0.000531	CcSEcCtD
Bupropion—Diarrhoea—Methotrexate—bone cancer	0.000116	0.000531	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000116	0.00176	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000115	0.00175	CbGpPWpGaD
Bupropion—Asthenia—Epirubicin—bone cancer	0.000114	0.000521	CcSEcCtD
Bupropion—Pruritus—Epirubicin—bone cancer	0.000113	0.000514	CcSEcCtD
Bupropion—Dizziness—Methotrexate—bone cancer	0.000112	0.000513	CcSEcCtD
Bupropion—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000109	0.00166	CbGpPWpGaD
Bupropion—Diarrhoea—Epirubicin—bone cancer	0.000109	0.000497	CcSEcCtD
Bupropion—Hypersensitivity—Doxorubicin—bone cancer	0.000109	0.000495	CcSEcCtD
Bupropion—Vomiting—Methotrexate—bone cancer	0.000108	0.000494	CcSEcCtD
Bupropion—Rash—Methotrexate—bone cancer	0.000107	0.000489	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—bone cancer	0.000107	0.000489	CcSEcCtD
Bupropion—Headache—Methotrexate—bone cancer	0.000107	0.000486	CcSEcCtD
Bupropion—Asthenia—Doxorubicin—bone cancer	0.000106	0.000482	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000105	0.0016	CbGpPWpGaD
Bupropion—Dizziness—Epirubicin—bone cancer	0.000105	0.00048	CcSEcCtD
Bupropion—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000104	0.00158	CbGpPWpGaD
Bupropion—Pruritus—Doxorubicin—bone cancer	0.000104	0.000476	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000102	0.00154	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000101	0.00154	CbGpPWpGaD
Bupropion—Vomiting—Epirubicin—bone cancer	0.000101	0.000462	CcSEcCtD
Bupropion—Nausea—Methotrexate—bone cancer	0.000101	0.000461	CcSEcCtD
Bupropion—Diarrhoea—Doxorubicin—bone cancer	0.000101	0.00046	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.0001	0.00152	CbGpPWpGaD
Bupropion—Rash—Epirubicin—bone cancer	0.0001	0.000458	CcSEcCtD
Bupropion—Dermatitis—Epirubicin—bone cancer	0.0001	0.000458	CcSEcCtD
Bupropion—Headache—Epirubicin—bone cancer	9.97e-05	0.000455	CcSEcCtD
Bupropion—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.86e-05	0.00149	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.77e-05	0.00148	CbGpPWpGaD
Bupropion—Dizziness—Doxorubicin—bone cancer	9.74e-05	0.000444	CcSEcCtD
Bupropion—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.69e-05	0.00147	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.64e-05	0.00146	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.56e-05	0.00145	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.5e-05	0.00144	CbGpPWpGaD
Bupropion—Nausea—Epirubicin—bone cancer	9.45e-05	0.000431	CcSEcCtD
Bupropion—Vomiting—Doxorubicin—bone cancer	9.36e-05	0.000427	CcSEcCtD
Bupropion—Rash—Doxorubicin—bone cancer	9.29e-05	0.000424	CcSEcCtD
Bupropion—Dermatitis—Doxorubicin—bone cancer	9.28e-05	0.000423	CcSEcCtD
Bupropion—Headache—Doxorubicin—bone cancer	9.23e-05	0.000421	CcSEcCtD
Bupropion—Nausea—Doxorubicin—bone cancer	8.75e-05	0.000399	CcSEcCtD
Bupropion—CYP2A6—Metabolism—NT5C3A—bone cancer	8.66e-05	0.00131	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—MDM2—bone cancer	8.5e-05	0.00129	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.44e-05	0.00128	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NDUFA12—bone cancer	8.43e-05	0.00128	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.36e-05	0.00127	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.29e-05	0.00126	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.28e-05	0.00125	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NDUFA12—bone cancer	8.26e-05	0.00125	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.24e-05	0.00125	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.17e-05	0.00124	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	8.17e-05	0.00124	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—BRAF—bone cancer	7.77e-05	0.00118	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.47e-05	0.00113	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.47e-05	0.00113	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NDUFA12—bone cancer	7.14e-05	0.00108	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.08e-05	0.00107	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NT5C3A—bone cancer	6.98e-05	0.00106	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.98e-05	0.00106	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NT5C3A—bone cancer	6.84e-05	0.00104	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—MDM2—bone cancer	6.51e-05	0.000987	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NT5C3A—bone cancer	5.91e-05	0.000896	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NDUFA12—bone cancer	5.86e-05	0.000888	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NDUFA12—bone cancer	5.81e-05	0.00088	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.46e-05	0.000828	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.39e-05	0.000817	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NDUFA12—bone cancer	4.96e-05	0.000752	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NT5C3A—bone cancer	4.85e-05	0.000736	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NT5C3A—bone cancer	4.81e-05	0.000729	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NT5C3A—bone cancer	4.11e-05	0.000623	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NDUFA12—bone cancer	3.83e-05	0.000581	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ENO2—bone cancer	3.79e-05	0.000575	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—DHFR—bone cancer	3.52e-05	0.000533	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GNA11—bone cancer	3.29e-05	0.000498	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NT5C3A—bone cancer	3.17e-05	0.000481	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ENO2—bone cancer	3.06e-05	0.000464	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ENO2—bone cancer	3e-05	0.000454	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP3A4—bone cancer	2.98e-05	0.000452	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—DHFR—bone cancer	2.84e-05	0.00043	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—DHFR—bone cancer	2.78e-05	0.000421	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GNA11—bone cancer	2.65e-05	0.000402	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GNA11—bone cancer	2.6e-05	0.000394	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ENO2—bone cancer	2.59e-05	0.000393	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTP1—bone cancer	2.55e-05	0.000386	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP3A4—bone cancer	2.4e-05	0.000364	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—DHFR—bone cancer	2.4e-05	0.000364	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP3A4—bone cancer	2.36e-05	0.000357	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GNA11—bone cancer	2.25e-05	0.00034	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ENO2—bone cancer	2.13e-05	0.000322	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ENO2—bone cancer	2.11e-05	0.00032	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTP1—bone cancer	2.06e-05	0.000312	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP3A4—bone cancer	2.04e-05	0.000309	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.03e-05	0.000307	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTP1—bone cancer	2.01e-05	0.000305	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—DHFR—bone cancer	1.97e-05	0.000299	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—DHFR—bone cancer	1.96e-05	0.000296	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GNA11—bone cancer	1.84e-05	0.000279	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GNA11—bone cancer	1.83e-05	0.000277	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ENO2—bone cancer	1.8e-05	0.000273	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTP1—bone cancer	1.74e-05	0.000264	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP3A4—bone cancer	1.67e-05	0.000253	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—DHFR—bone cancer	1.67e-05	0.000253	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP3A4—bone cancer	1.66e-05	0.000251	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.65e-05	0.00025	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GNA11—bone cancer	1.56e-05	0.000237	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTP1—bone cancer	1.43e-05	0.000217	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTP1—bone cancer	1.42e-05	0.000215	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000215	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.41e-05	0.000214	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ENO2—bone cancer	1.39e-05	0.000211	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS2—bone cancer	1.32e-05	0.0002	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—DHFR—bone cancer	1.29e-05	0.000195	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTP1—bone cancer	1.21e-05	0.000184	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GNA11—bone cancer	1.21e-05	0.000183	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS2—bone cancer	1.07e-05	0.000162	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS2—bone cancer	1.04e-05	0.000158	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTP1—bone cancer	9.35e-06	0.000142	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS2—bone cancer	9.02e-06	0.000137	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS2—bone cancer	7.41e-06	0.000112	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS2—bone cancer	7.34e-06	0.000111	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS2—bone cancer	6.27e-06	9.51e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS2—bone cancer	4.84e-06	7.34e-05	CbGpPWpGaD
